CIK: 0001538653 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value ($000): $2,402,001 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| W | WAYFAIR INC | 4,096,996 | $925,143 | 38.5% | $53.95 | +392.1% | CL A | 94419L101 |
| CACC | CREDIT ACCEP CORP MICH | 1,738,758 | $601,854 | 25.1% | $107.75 | +203.1% | COM | 225310101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $342,756 | 14.3% | $129.96 | -33.9% | SHS EURO | G2143T103 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $208,273 | 8.7% | $81.92 | +29.1% | COM | 981419104 |
| YELP | YELP INC | 5,151,016 | $168,284 | 7.0% | $30.67 | -14.4% | CL A | 985817105 |
| — | VAPOTHERM INC | 2,557,243 | $68,688 | 2.9% | $37.84 | — | COM | 922107107 |
| — | SYSTEMAX INC | 1,777,633 | $63,799 | 2.7% | $9.46 | — | COM | 871851101 |
| BFH | ALLIANCE DATA SYSTEMS CORP | 265,370 | $19,664 | 0.8% | $118.19 | -61.1% | COM | 018581108 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $3,259 | 0.1% | $1.03 | +35.7% | COM | 53566P109 |
| — | AGEX THEREPEUTICS INC | 185,185 | $281 | 0.0% | $2.99 | — | COM | 00848H108 |